Cornerstone Capital Management Holdings’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$125K Buy
15,411
+511
+3% +$5.8K ﹤0.01% 1153
2017
Q3
$216K Buy
+14,900
New +$204K ﹤0.01% 1151
2017
Q1
Sell
-90,500
Closed -$1.1M 1306
2016
Q4
$1.1M Buy
+90,500
New +$960K 0.01% 933
2016
Q3
Sell
-8,600
Closed -$82K 1384
2016
Q2
$82K Sell
8,600
-29,452
-77% -$242K ﹤0.01% 1286
2016
Q1
$269K Buy
38,052
+18,152
+91% +$133K ﹤0.01% 1160
2015
Q4
$208K Buy
+19,900
New +$195K ﹤0.01% 1203
2015
Q3
Sell
-1,550
Closed -$10K 1502
2015
Q2
$10K Sell
1,550
-10,900
-88% -$71.5K ﹤0.01% 1396
2015
Q1
$84K Sell
12,450
-48,400
-80% -$361K ﹤0.01% 1280
2014
Q4
$487K Buy
60,850
+19,300
+46% +$82.8K 0.01% 979
2014
Q3
$146K Buy
41,550
+29,000
+231% +$122K ﹤0.01% 1137
2014
Q2
$59K Buy
12,550
+10,550
+528% +$64.4K ﹤0.01% 1231
2014
Q1
$19K Buy
+2,000
New +$18.1K ﹤0.01% 1284

Other funds holding CYTK